Cladribine (trade names Litak and Movectro) is a drug used to treat hairy cell leukemia (HCL leukemic reticuloendotheliosis) and multiple sclerosis. Its chemical name is 2-chlorodeoxyadenosine (2CDA).As a purine analog it is a synthetic anti-cancer agent that also suppresses the immune system. Chemically it mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase which interferes with the cell’s ability to process DNA.
This page contains content from the copyrighted Wikipedia article "Cladribine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
